End-of-day quote
Shenzhen S.E.
03:30:00 06/05/2024 am IST
|
5-day change
|
1st Jan Change
|
31.35
CNY
|
-1.79%
|
|
+0.29%
|
-4.01%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
20,858
|
29,138
|
30,220
|
36,225
|
35,644
|
34,214
|
-
|
-
|
Enterprise Value (EV)
1 |
20,089
|
28,673
|
27,054
|
33,743
|
34,373
|
33,686
|
32,686
|
33,550
|
P/E ratio
|
29.3
x
|
472
x
|
54.6
x
|
56.6
x
|
62.8
x
|
55
x
|
44.5
x
|
38
x
|
Yield
|
2.51%
|
-
|
1.46%
|
1.52%
|
1.53%
|
0.67%
|
1.36%
|
1.52%
|
Capitalization / Revenue
|
4.67
x
|
10.6
x
|
9.88
x
|
10.4
x
|
10.6
x
|
8.57
x
|
7.3
x
|
6.24
x
|
EV / Revenue
|
4.49
x
|
10.5
x
|
8.85
x
|
9.69
x
|
10.2
x
|
8.44
x
|
6.98
x
|
6.12
x
|
EV / EBITDA
|
18.4
x
|
83.6
x
|
30
x
|
31.7
x
|
33.9
x
|
32.3
x
|
27.2
x
|
24.4
x
|
EV / FCF
|
-
|
39.1
x
|
-
|
90.6
x
|
-
|
58.2
x
|
44.4
x
|
44.1
x
|
FCF Yield
|
-
|
2.56%
|
-
|
1.1%
|
-
|
1.72%
|
2.25%
|
2.27%
|
Price to Book
|
3.21
x
|
5.38
x
|
3.79
x
|
4.61
x
|
4.54
x
|
4.16
x
|
4.06
x
|
3.88
x
|
Nbr of stocks (in thousands)
|
10,46,016
|
10,28,513
|
11,06,137
|
11,02,746
|
10,91,359
|
10,91,359
|
-
|
-
|
Reference price
2 |
19.94
|
28.33
|
27.32
|
32.85
|
32.66
|
31.35
|
31.35
|
31.35
|
Announcement Date
|
28/02/20
|
29/03/21
|
28/03/22
|
28/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,470
|
2,739
|
3,058
|
3,482
|
3,365
|
3,989
|
4,746
|
5,485
|
EBITDA
1 |
1,093
|
343.2
|
900.4
|
1,064
|
1,013
|
1,006
|
1,224
|
1,401
|
EBIT
1 |
846.1
|
79.22
|
586.2
|
727.4
|
656
|
634.1
|
930.5
|
1,057
|
Operating Margin
|
18.93%
|
2.89%
|
19.17%
|
20.89%
|
19.49%
|
15.89%
|
19.6%
|
19.26%
|
Earnings before Tax (EBT)
1 |
851.3
|
56.74
|
599.8
|
713.7
|
641.8
|
721.1
|
938.2
|
1,076
|
Net income
1 |
715.2
|
60.86
|
533.7
|
636.9
|
580.1
|
661.7
|
814.7
|
944.4
|
Net margin
|
16%
|
2.22%
|
17.45%
|
18.29%
|
17.24%
|
16.59%
|
17.17%
|
17.22%
|
EPS
2 |
0.6800
|
0.0600
|
0.5000
|
0.5800
|
0.5200
|
0.5950
|
0.7300
|
0.8367
|
Free Cash Flow
1 |
-
|
732.8
|
-
|
372.4
|
-
|
578.6
|
736.1
|
760.4
|
FCF margin
|
-
|
26.76%
|
-
|
10.7%
|
-
|
14.5%
|
15.51%
|
13.86%
|
FCF Conversion (EBITDA)
|
-
|
213.53%
|
-
|
34.99%
|
-
|
57.54%
|
60.15%
|
54.26%
|
FCF Conversion (Net income)
|
-
|
1,203.91%
|
-
|
58.47%
|
-
|
87.43%
|
90.35%
|
80.52%
|
Dividend per Share
2 |
0.5000
|
-
|
0.4000
|
0.5000
|
0.5000
|
0.2100
|
0.4250
|
0.4750
|
Announcement Date
|
28/02/20
|
29/03/21
|
28/03/22
|
28/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
1 |
0.1200
|
0.2200
|
0.0900
|
0.1800
|
0.0900
|
0.1900
|
0.1100
|
0.1300
|
0.0900
|
0.1800
|
0.1600
|
0.1400
|
0.1100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/03/22
|
18/04/22
|
09/08/22
|
24/10/22
|
28/03/23
|
18/04/23
|
24/08/23
|
30/10/23
|
25/03/24
|
22/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
769
|
465
|
3,166
|
2,482
|
1,271
|
528
|
1,528
|
664
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
733
|
-
|
372
|
-
|
579
|
736
|
760
|
ROE (net income / shareholders' equity)
|
11.1%
|
1.03%
|
7.6%
|
8.13%
|
7.35%
|
7.69%
|
9.23%
|
10.3%
|
ROA (Net income/ Total Assets)
|
9.15%
|
0.83%
|
6.6%
|
6.71%
|
-
|
6.95%
|
8.3%
|
8.65%
|
Assets
1 |
7,819
|
7,324
|
8,081
|
9,500
|
-
|
9,108
|
9,469
|
10,658
|
Book Value Per Share
2 |
6.200
|
5.270
|
7.210
|
7.120
|
7.190
|
7.540
|
7.710
|
8.080
|
Cash Flow per Share
2 |
1.440
|
1.310
|
1.110
|
0.8700
|
0.7500
|
1.500
|
0.7000
|
1.070
|
Capex
1 |
-
|
642
|
481
|
598
|
670
|
481
|
501
|
502
|
Capex / Sales
|
-
|
23.43%
|
15.72%
|
17.18%
|
19.92%
|
12.05%
|
10.71%
|
9.16%
|
Announcement Date
|
28/02/20
|
29/03/21
|
28/03/22
|
28/03/23
|
25/03/24
|
-
|
-
|
-
|
Last Close Price
31.35
CNY Average target price
37
CNY Spread / Average Target +18.02% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.01% | 4.81B | | +21.41% | 43.48B | | +20.67% | 22.65B | | +14.56% | 14.73B | | +14.21% | 13.79B | | +48.11% | 12.04B | | -8.37% | 7.08B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +11.90% | 5.47B |
Generic Pharmaceuticals
|